Delivery Order SPE2DB24D3015-SPE2DB25FGASD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on July 29, 2025, with a ceiling value of $2,106.02 and an ultimate completion date of August 19, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support...
- The Defense Logistics Agency awarded a $30,963.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 14, 2025, with an ultimate completion date of September 5, 2025. This is a non-set-aside, competitively awarded delivery order being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Varivax vaccine with diluents, valued at $2,106.02 with a completion date of September 3, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $19,808.64 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 13, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract issued under a child delivery order structure. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order derives from AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,158.88 on August 14, 2025, for Varivax vaccine with diluents to be delivered to Conshohocken, Pennsylvania, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Varivax vaccine with diluents, with a ceiling value of $1,032.11 and an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,042.56 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. The contract, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed-price pricing and requires performance at the contractor's Conshohocken, Pennsylvania facility. This is an unset-aside award made through competitive procurement, reflecting AmerisourceBergen's established capability to meet federal vaccine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on July 22, 2025, with a ceiling value of $5,160.55 and an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The vaccine delivery will...
- The Defense Logistics Agency awarded a $103,211 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. This competitively awarded contract, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The vaccine delivery will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $13,553.28 under a firm fixed price contract type. The delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this requirement as a child contract under its larger Indefinite Delivery...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGASDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 22, 2025, with a ceiling value of $1,053.01 and an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills vaccine and pharmaceutical requirements for the Defense Health Agency and other government healthcare systems. The Varivax delivery order represents a routine pharmaceutical procurement within the contractor's extensive portfolio of federal medical product deliveries, which consistently demonstrate the company's capability to meet competitive federal procurement requirements across multiple therapeutic domains. The firm fixed-price structure and short performance timeline reflect the time-sensitive nature of vaccine procurement and distribution to support military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/22/25 |